NEW! Subscribe to Medtech Pro and get one or all of our reports, plus much more.

Q3 2019 Emerging Medical Technologies Spotlight

Virtual Events Starts: Friday, September 27

This product available individually or as part of the Medtech Pro platform

Q3 Spotlight Sponsors

An angel investment group created to leverage cross-pacific business opportunities by investing in early stage life science and healthcare companies with an Asia connection with the goals of: (1) Provide a funding source to emerging life science and healthcare companies that have a business focus on China/Asia and are pre-venture capital or do not fit traditional funding models, (2) Identify and present well-vetted cross-border investment opportunities to the membership, (3)Simplify the investment vehicle for members, companies and follow-on investors, and (4) Contribute business, scientific and regional expertise to companies to improve probability for success

Greenlight Guru is the only quality management platform designed specifically for medical devices companies. The platform helps companies get safer products to market faster, simplifies FDA and ISO regulatory compliance and provides a single source of truth by connecting the management of all quality processes like CAPAs, risk, audits and more. Greenlight Guru's platform is used by thousands of users across the globe to push beyond baseline compliance achieving True Quality.

Insurance Solutions for the Medical Technology and Life Sciences Industry. Medmarc is the longest serving underwriter of products liability insurance for manufacturers and distributors of medical technology and life sciences products.

For more than 30 years Ximedica has provided a unique growth platform enabling organizations to successfully deploy medical technology products into the market. Ximedica was formed in 1985 by two Rhode Island School of Design (RISD) graduates, Aidan Petrie and Stephen Lane. From those earliest days to today, the application of "human-centered" design thinking to the innovation and product creation processes remains central to the company's success. In 2014 SV Life Sciences purchased a majority stake in the firm, recognizing that Ximedica is unique in providing a comprehensive service platform - a much needed option in the evolving ecosystem of outsourced medical device development. Throughout its history Ximedica has unearthed new opportunities for clients, solved difficult development challenges, delivered cutting edge innovative solutions and added considerably to patent counts.